European Agency Again Recommends Against Approval of Raxone as DMD Therapy
News
An advisory committee of the European Medicines Agency (EMA) has issued another negative recommendation after re-examining a request to extend Raxone (idebenone) for use in treating Duchenne muscular dystrophy (DMD). The EMA’s ... Read more